Odenton Dialysis in Odenton, Maryland - Dialysis Center

Odenton Dialysis is a medicare approved dialysis facility center in Odenton, Maryland and it has 19 dialysis stations. It is located in Anne Arundel county at 1360 Blair Drive, Odenton, MD, 21113. You can reach out to the office of Odenton Dialysis at (410) 674-3918. This dialysis clinic is managed and/or owned by Davita. Odenton Dialysis has the following ownership type - Profit. It was first certified by medicare in August, 2016. The medicare id for this facility is 212711 and it accepts patients under medicare ESRD program.

Name	Odenton Dialysis
Location	1360 Blair Drive, Odenton, Maryland
No. of Dialysis Stations	19
Medicare ID	212711
Managed By	Davita
Ownership Type	Profit
Late Shifts	No

Dialysis Facilities may have multiple NPI numbers. We have found possible NPI number/s associated with Odenton Dialysis from NPPES records by matching pattern on the basis of name, address, phone number etc. Please use this information accordingly.

NPI Number	1699159228
Organization Name	Odenton Dialysis
Doing Business As	Ahern Dialysis Llc
Address	1360 Blair Dr Odenton, Maryland, 21113
Phone Number	(410) 674-3918

Dialysis patients with Hemoglobin data

7

Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.

• Hemodialysis

  Adult patients getting regular hemodialysis at the center	23
  Adult patient months included in Kt/V greater than or equal to 1.2	93
  Percentage of adult patients getting regular hemodialysis at the center	97
  Percentage of pediatric patients getting regular hemodialysis at the center

An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Odenton Dialysis with elevated calcium levels.

Patients with hypercalcemia	23
Hypercalcemia patient months	93
Patients with Serumphosphor	26
Patients with Serumphosphor less than 3.5 mg/dL	6
Patients with Serumphosphor from 3.5 to 4.5 mg/dL	12
Patients with Serumphosphor from 4.6 to 5.5 mg/dL	29
Patients with Serumphosphor from 5.6 to 7 mg/dL	32
Patients with Serumphosphor greater than 7 mg/dL	21

The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.

Patients included in arterial venous fistula and catheter summaries	78
Patient months included in arterial venous fistula and catheter summaries	176
Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment	77
Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer	6

The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.

Standard Hospitalization Summary Ratio(SHR) Year	January, 2016 - December, 2016
Patients in facility's Hospitalization Summary	3
Hospitalization Rate in facility	(Not Available)
Hospitalization Rate: Upper Confidence Limit
Hospitalization Rate: Lower Confidence Limit